Equity Overview
Price & Market Data
Price: $0.02
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $5,235,880
Volume: 0
Performance Metrics
1 Week: 110.5%
1 Month: 39.22%
3 Months: 29.03%
6 Months: -23.08%
1 Year: -42.11%
YTD: -33.33%
Company Details
Employees: 13
Sector: Health technology
Industry: Pharmaceuticals: other
Country: Canada
Details
Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company in Canada. The company's leading drug candidates comprises PEX010 oral psilocybin, PEX020 oral psilocin, and PEX030 sublingual psilocin. It also develops AEX010 ayahuasca, which is in preclinical stage; and AEX020 monoamine oxidase inhibitor and is in preclinical stage. In addition, the company provides in-house human clinical trials, as well as license technology to drug developers, researchers, and other licensed parties. Filament Health Corp. is headquartered in Burnaby, Canada.